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Abstract Saporin is a single chain ribosome-inactivating pro-
tein produced by the plant Saponaria o⁄cinalis. Several iso-
forms of saporin have been isolated from various parts of the
plant. In the present study recombinant saporin isoforms 5 and 6
were produced in Escherichia coli. Saporin-6 was found to be
more active than saporin-5 in its N-glycosidase, cytotoxic, and
genomic DNA fragmentation activities. Earlier, saporin has
been shown to bind low-density lipoprotein receptor-related pro-
tein (LRP), however, in this study the sensitivities of LRP-
negative and LRP-positive cell lines were found to be similar
towards saporin-6 toxicity suggesting the internalization of
saporin not to be solely dependent on the expression of LRP
on eukaryotic cells.
) 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
Key words: Ribosome-inactivating protein; Toxin;
Ribosome; Immunotoxin; Ribotoxin
1. Introduction
Ribosome-inactivating proteins (RIPs) from plants are toxic
translation inhibitors that inactivate ribosomes by catalyzing
the hydrolysis of a speci¢c N-glycosidic bond of large rRNA
[1]. RIPs have been classi¢ed into two types; type I RIPs, e.g.
saporin, trichosanthin and pokeweed antiviral protein (PAP),
are single chain proteins and do not have a second cell bind-
ing domain unlike their type II counterparts that include ricin
and abrin. Because of the absence of a binding domain, the
single chain type I RIPs lack the non-speci¢c cytotoxicity
shown by the type II RIPs and are therefore toxins of choice
for the construction of immunotoxins. The site of action of
RIPs in 28S rRNA is located in a highly conserved, purine-
rich stem and loop structure termed as K-sarcin/ricin loop.
The target adenine residue, A4324 of rat 28S rRNA, com-
prises a part of tetranucleotide ‘GA4324GA’ in the loop [2].
Most of the single chain RIPs also remove an equivalent
adenine residue, A2660, from 23S rRNA of Escherichia coli
ribosomes [3]. The catalytic depurination disrupts the binding
of elongation factors to the ribosomes, thus arresting the pro-
tein synthesis at the translocation step [4].
Saporin, isolated from the plant Saponaria o⁄cinalis, is one
of the most active single chain RIPs. Saporin belongs to a
multigene family that encodes its several isoforms, which dif-
fer in their physico-chemical as well as biological properties
[5]. More than nine isoforms of saporin have been isolated
from various parts of S. o⁄cinalis plant. Isoforms of saporin
are designated by source tissue and the peak number in which
they were obtained in the ion-exchange chromatography of
the crude extract of the tissue [5,6]. Saporin-6 constitutes
the major peak (peak 6) of preparation from seeds, account-
ing for approximately 0.4% of the whole seed weight or 7% of
the total seed protein [6]. This preparation, however, con-
tained a mixture of at least four forms of saporin-6 showing
heterogeneity at positions 48 and 91 [7,8]. At position 48
either Asp or Glu, and at position 91 either Arg or Lys
were found [7,8]. The di¡erent saporin isoforms have been
shown to have immunological cross-reactivity [9]. Genomic
clones of several saporin seed isoforms obtained by polymer-
ase chain reaction (PCR) ampli¢cation of S. o⁄cinalis ge-
nomic DNA have been designated as genomic clone-1 to 5
[10]. The derivation of amino acid sequences of these clones
revealed that genomic clone-1, 4 and 5 referred to saporin
isoforms 1, 4 and 5 respectively, whereas genomic clone-2
and 3 referred to two of the four forms of saporin-6 having
Asp48 and Lys91, and Glu48 and Lys91 respectively [10]. All
these isoforms show a very high sequence similarity, and
among the isoforms di¡erences were observed only at 13 po-
sitions out of which seven positions show change in polarity
or charge of amino acid. Among various isoforms only sap-
orin-1 and saporin-3 from roots have been found to be gly-
cosylated [5]. Saporin extracted from the seeds of S. o⁄cinalis
has been shown to bind to K2-macroglobulin receptor, also
called as low-density lipoprotein receptor-related protein
(LRP) [11]. LRP is expressed in many tissues and cell types,
particularly in ¢broblasts, monocytes and hepatocytes, and is
responsible for the uptake and clearance of macromolecular
complexes between proteinases and K2-macroglobulin [11].
We have shown recently that the cytotoxic activity of sapor-
in-6 results due to the combined manifestation of its N-gly-
cosidase and internucleosomal DNA fragmentation activities
[12].
In the present study, we have functionally compared two
isoforms of saporin namely, saporin-5 and 6. The catalytic
and cytotoxic activities of saporin-6 were found to be signi¢-
cantly higher than of saporin-5. However, the cytotoxicity of
saporin was not found to be dependent on the expression of
LRP. Also, the di¡erence in the cytotoxic activities of the two
isoforms was found to be solely due to the di¡erence in their
catalytic activities.
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2. Materials and methods
CHO-K1 and CHO-13-5-1 cell lines were a generous gift from Dr.
David J. FitzGerald, N.I.H., USA.
2.1. Cloning, expression, puri¢cation and structural characterization of
saporin isoforms
Genomic DNA, extracted from the seeds of S. o⁄cinalis was used
as template to amplify DNA coding for the two saporin isoforms by
PCR. The published sequence of saporin gene was used to design
PCR primers [13]. The ampli¢ed DNAs were cloned into the expres-
sion vector pVex11, containing a T7 promoter, multiple cloning site
and a T7 transcription terminator.
Saporin isoforms were expressed in BL21 (VDE3) strain of E. coli.
Bacterial cells were transformed with the desired construct and grown
at 37‡C, in super broth containing 100 Wg/ml ampicillin. At an OD600
of 2.0, the cells were induced with 1 mM isopropyl thiogalactose
(IPTG), and harvested 2 h later. The recombinant proteins were pu-
ri¢ed from the inclusion bodies following the method of Buchner et al.
[14] as described earlier [12]. Proteins were isolated from the inclusion
bodies by denaturation, and after renaturation they were puri¢ed by
successive chromatography on S-Sepharose and TSK3000 gel ¢ltra-
tion columns [12].
The secondary structure of saporin isoforms was analyzed using
circular dichroism (CD) as described earlier [12].
2.2. Assay for speci¢c N-glycosidase activity
Rabbit reticulocyte lysate was taken as the source of ribosomes and
treated with di¡erent concentrations of proteins at 30‡C for 30 min
[12,15]. The reaction was stopped with sodium dodecyl sulfate (SDS)
and total RNA was isolated using Trizol reagent as per manufactur-
er’s instructions. The RNA pellet was dissolved in water, and half of
the RNA sample was treated with aniline-acetate. The aniline-treated
and untreated samples were electrophoresed on 2% agarose gel and
the RNA was visualized by ethidium bromide staining [12].
2.3. Assay for in vitro protein synthesis inhibition
The inhibitory activity of saporin isoforms towards in vitro protein
synthesis was assayed as described [12,16]. Several dilutions of the
toxin were incubated with rabbit reticulocyte lysate at 30‡C for 60
min; the proteins were precipitated with 15% trichloroacetic acid and
harvested on glass ¢ber ¢lters. The dried ¢lters were counted using a
liquid scintillation counter. Activity was expressed as percentage of
control where no toxin was added.
2.4. Assay for genomic DNA fragmentation
U937 cells were used to evaluate the genomic DNA fragmentation
ability of saporin isoforms as described earlier [12]. DNA was isolated
from saporin-treated and control cells, run in a 1.5% agarose gel and
visualized by staining with ethidium bromide.
2.5. Cytotoxic activity of saporin isoforms
The cytotoxic activity of saporin isoforms was assayed on a variety
of cancer cell lines. Adherent cells were plated at a density of 5U103
cells/well in a 96-well plate in 0.2 ml of RPMI/DMEM (Dulbecco’s
modi¢ed Eagle’s medium) containing 10% fetal calf serum (FCS) for
16 h. The medium was replaced with 0.2 ml leucine-free medium
containing 2% FCS for evaluating the cytotoxicity. The suspension
cells were seeded at 104 cells/well in 0.2 ml of leucine-free medium
containing 2% FCS and used immediately. The cells were incubated
with various concentrations of toxins, diluted in 0.2% human serum
albumin (HSA) in Dulbecco’s phosphate-bu¡ered saline for 34 h fol-
lowed by labeling with 0.75 WCi [3H]leucine per well for 2 h. The cells
after freezing and thawing were harvested on ¢ltermats using a 96-well
plate automated harvester and the ¢lters were counted using an LKB
L-plate counter. Activity was plotted as percentage of control where
no toxin was added to the cells.
Cytotoxicity of saporin isoforms was assayed on HeLa cells infected
with adenovirus as described by Fernandez-Puentes and Carrasco [17].
HeLa cells, 2U104 cells/well, were grown in a 96-well culture plate for
12 h at 37‡C. The medium was replaced with 0.2 ml leucine-free
RPMI containing 1% FCS. Adenovirus, propagated and isolated
from HEK 293 cells, and di¡erent dilutions of saporin isoforms, in
0.2% HSA, were added to the cells and incubated for 5 h. The cells
were labeled with 0.1 WCi [3H]leucine per well for 2 h at 37‡C, har-
vested onto ¢ltermats and counted as described above.
3. Results and discussion
In the present study we have investigated the mechanism of
saporin cytotoxicity using recombinant saporin-5 and saporin-
6 isoforms of S. o⁄cinalis. Saporin-6 refers to the form having
Asp at position 48 and Lys at position 91, thus representing
genomic clone-2 of Barthelemy et al. [10]. The sequence of
saporin-5, which corresponds to genomic clone-5 of saporin
described by Barthelemy et al. [10], is identical to the deduced
amino acid sequence of saporin leaf cDNA except that the
latter has a Ser at position 99 whereas a Leu is present at this
position in saporin-5.
3.1. Expression, puri¢cation and structural characterization
Both saporin-5 and saporin-6 proteins were overexpressed
in E. coli BL21 (VDE3) cells and puri¢ed from the inclusion
bodies. The typical yield of puri¢ed saporin-5 was in the range
of 18^20 mg/l culture whereas that of saporin-6 was 3^5 mg/l
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Fig. 1. Structural and catalytic properties of saporin isoforms. A:
Far UV CD spectra. The spectra were acquired at a scan speed of
50 nm/min with a sensitivity of 5 mdeg and a response time of 1 s.
Saporin-5 (dashed line) and saporin-6 (solid line). B: In vitro pro-
tein synthesis inhibitory activity. Rabbit reticulocyte lysate was
treated with various concentrations of saporin isoforms, and incor-
poration of [3H]leucine was measured into the newly synthesized
proteins. Saporin-5 (b) and saporin-6 (F).
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culture. The puri¢ed saporin-6 was used to raise polyclonal
antibodies in rabbits. These antibodies reacted equally well
with saporin-5 and saporin-6 indicating similar antigenic de-
terminants on both the isoforms (data not shown).
The secondary structure of saporin isoforms was evaluated
by CD spectral analysis. Saporin-5 and saporin-6 showed sim-
ilar CD spectra, characteristic of a compactly folded K+L
structure, in the far ultraviolet (UV) range 200^250 nm (Fig.
1A). Compared to saporin-6, saporin-5 had a relatively higher
L-sheet and a reduced K-helical content (Fig. 1A). These spec-
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Fig. 2. Enzymatic activity of saporin isoforms. A: N-glycosidase activity. Rabbit reticulocyte lysate was treated with indicated concentrations
of saporin isoforms. Total RNA was extracted, and aniline-treated and untreated RNA was resolved on a 2% agarose gel. B: Genomic DNA
fragmentation activity. U937 cells were incubated with indicated concentrations of saporin isoforms for 48 h. Genomic DNA was isolated, run
on a 1.5% agarose gel and visualized by ethidium bromide staining. Molecular weights in bp are indicated on the left.
Table 1
Cytotoxicity of saporin isoforms on LRP-positive and LRP-negative cells
Protein ID50 (Wg/ml)
LRP-positive LRP-negative
J774A.1 U937 HUT102 HeLa
Saporin-5 0.30Q 0.009 55.0Q 5.03 3.4 Q 0.35 s 80
Saporin-6 0.03Q 0.005 (10) 6.5Q 0.69 (8) 0.7 Q 0.04 (5) 15Q1.73 (s 5)
ID50 refers to the concentration of toxin required to inhibit cellular protein synthesis by 50%. All assays were carried out at least three times,
and results are expressed as meansQS.E.M. The numbers in parentheses refer to fold activity of saporin-6 compared to saporin-5 in the same
cell line.
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tra are similar to that observed for dianthin-30 and ricin
A-chain suggesting a similar structure for these functionally
related proteins [18].
3.2. Protein synthesis inhibitory activity
The protein synthesis inhibitory activity of saporin isoforms
was tested in an in vitro translation assay using rabbit retic-
ulocyte lysate. The lysate permits the translation of globin
mRNA when suitable energy source and amino acids are sup-
plied to optimize the reaction. The lysate was treated with
di¡erent concentrations of saporin-5 or saporin-6, and the
inhibition of protein synthesis was measured as decrease in
the incorporation of [3H]leucine in nascent polypeptides syn-
thesized. Both the isoforms caused a dose-dependent inhibi-
tion of protein synthesis (Fig. 1B). However, saporin-6 was
found to be about 10-fold more active than saporin-5 in in-
hibiting in vitro protein synthesis (Fig. 1B). The respective
ID50 values of saporin-6 and saporin-5 were 2.6 Q 0.11 and
30Q 1.15 ng/ml. This agrees with the earlier observation sug-
gesting that leaf isoforms have one order of magnitude lower
inhibitory activity in rabbit reticulocyte lysate than the seed
isoforms [5].
3.3. Speci¢c N-glycosidase activity
RIPs cleave the N-glycosidic bond at A4324 of 28S rRNA
when intact rat ribosomes are the substrate. This depurination
makes the site susceptible to amine-dependent cleavage lead-
ing to the release of a 390 bases long 3P rRNA fragment called
as Endo-fragment [19]. To evaluate the speci¢c RNA N-gly-
cosidase activity of saporin isoforms, rabbit reticulocyte lysate
was taken as the source of ribosomes. The total RNA was
isolated from the toxin-treated lysate, treated with aniline and
analyzed on agarose gels. Both the isoforms speci¢cally re-
leased the 390 bases long Endo-fragment on aniline treatment
at a concentration as low as 40 ng/ml (Fig. 2A). However, at
lower concentration with saporin-5 the digestion of 28S rRNA
was incomplete indicating saporin-5 to have a lower activity
compared to saporin-6 in this semi-quantitative assay also
(Fig. 2A).
3.4. Genomic DNA fragmentation
Saporin has been shown to induce cell death via apoptosis
[20]. Internucleosomal degradation of DNA, re£ected as
DNA laddering, is a characteristic biochemical feature of ap-
optosis [12,20,21]. In this study the e¡ect of saporin isoforms
was compared on genomic DNA of U937 cells. U937 cells
were treated with various concentrations of two saporin iso-
forms and after 48 h genomic DNA was isolated from the
treated and untreated cells. As shown in Fig. 2B, DNA
from cells treated with 0.1 WM saporin-6 was found to be
fragmented, which intensi¢ed further at 1 WM concentration.
Saporin-5 appeared to be less active in causing genomic DNA
fragmentation and a much reduced fragmentation was ob-
served with 1 WM protein (Fig. 2B).
3.5. Cytotoxic activity
The cytotoxic activity of saporin isoforms was studied on
both LRP-positive and LRP-negative cell lines. The cell lines
J774A.1 (mouse monocyte macrophage) and U937 (human
histiocyte lymphoma) express LRP, whereas HUT102 (human
cutaneous T-cell lymphoma) and HeLa (human epitheloid
carcinoma) cells lack LRP [11]. The cells were treated with
various concentrations of both saporin isoforms, and decrease
in the incorporation of [3H]leucine in toxin-treated cells as
compared to the control was taken as the measure of cytotox-
icity. Both the isoforms showed a dose-dependent toxicity on
all the cell lines studied, however, the toxicity varied with the
cell line (Table 1). Among the cell lines tested, J774A.1 was
found to be the most sensitive cell line. The activity of sapor-
in-6 was found to be 10-fold higher than of saporin-5 on
J774A.1 (Table 1). Saporin-6 was found to be more active
than saporin-5 on all other cell lines also; the di¡erence of
activity between the two isoforms varied between 5- and 20-
fold depending on the cell line tested (Table 1). In this study
the LRP-negative cell lines used were found to have sensitiv-
ities similar to LRP-positive cell lines towards saporin toxicity
(Table 1).
To further investigate the involvement of LRP in the cyto-
toxic activity of saporin, the toxicity of saporin-6 was assayed
on LRP-positive Chinese hamster ovary cell line CHO-K1,
and its mutant CHO-13-5-1, which has been shown to have
no detectable LRP mRNA or protein [22]. Both CHO-K1 and
CHO-13-5-1 cells were found to have similar sensitivities to-
wards saporin-6 toxicity. The respective ID50 values of sapor-
in-6 on CHO-K1 and CHO-13-5-1 cells were 2.2 Q 0.15 and
3Q 0.20 Wg/ml. It has been shown that functional LRP is
required to mediate Pseudomonas exotoxin (PE) entry and
delivery to the cell interior [22,23]. The mutant CHO-13-5-1
cells showed s 100-fold resistance to PE compared to CHO-
K1 cells (data not shown).
Saporin isolated from the seeds has been shown to bind to
LRP [11], however, in the present study the sensitivities of
LRP-positive and LRP-negative cells were found to be sim-
ilar. Studies done on interactions of LRP and saporin have
shown that anti-LRP antibodies and lipoprotein lipase, a
known ligand of LRP, inhibit the cytotoxicity of saporin to
U937 cells [11]. Also, studies with a conjugate of saporin and
urokinase plasminogen activator (uPA) suggested the internal-
ization of the conjugate to be mediated by saporin and LRP
interactions [24,25]. Although the above observations suggest
LRP as one of the receptors through which saporin enters, the
lack of comparative studies with LRP-negative cell lines does
not rule out other possible mechanisms of entry. It is widely
accepted that type I RIPs and A-chain of type II RIPs can
also enter the cell cytosol through passive mechanisms such as
£uid-phase pinocytosis or non-speci¢c cell engulfment [26,27].
Recent studies have shown that trichosanthin binds to LRP as
well as another member of LDL receptor family, megalin [28],
suggesting that RIPs can enter the cells through various re-
ceptors of the same family. Therefore, one of the reasons of
similar cytotoxic activities of saporin isoforms in LRP-posi-
tive and LRP-negative cell lines could be the entry of toxin
into LRP-negative cells through receptors or mechanisms oth-
Table 2
Cytotoxicity of saporin isoforms on permeabilized HeLa cells
Protein ID50 (Wg/ml)
+Adenovirus 3Adenovirus
Saporin-5 20.0Q 2.33 s 80
Saporin-6 2.5Q 0.18 s 80
ID50 refers to the concentration of toxin required to inhibit cellular
protein synthesis by 50%. All assays were carried out at least three
times, and results are expressed as meansQS.E.M.
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er than LRP-mediated endocytosis. Similar sensitivities of
CHO-K1 cells and its mutant CHO-13-5-1 cells, which lack
LRP, to saporin-6 strongly suggest that binding and internal-
ization of saporin is not mediated through LRP.
To ¢nd out if the di¡erence in activities of saporin isoforms
on various cell lines is due to a di¡erence in their internal-
ization e⁄ciencies, the cytotoxicity of isoforms was tested on
HeLa cells infected with adenovirus. The adenoviral infection
makes the cells permeable and will eliminate any di¡erences
that might exist in the e⁄ciency of saporin isoforms to enter
the cells. The cells were treated with various concentrations of
saporin-5 or saporin-6 in the presence or absence of adenovi-
rus and decrease in the incorporation of [3H]leucine, in toxin-
treated cells, was taken as the measure of cytotoxicity. Both
saporin-5 and saporin-6 showed a dose-dependent toxicity to
the infected cells (data not shown). As shown in Table 2
saporin-6 was eight-fold more active than saporin-5 in adeno-
virus infected cells, whereas in uninfected cells ID50 could not
be achieved up to 80 Wg/ml for both the isoforms, indicat-
ing that the di¡erence in the cytotoxicity is a re£ection of
the di¡erence in the catalytic activity of the two isoforms (Ta-
ble 2).
In conclusion, saporin-6 has been shown to have higher N-
glycosidase and DNA fragmentation activities than saporin-5
that re£ect in a similar di¡erence in their cytotoxic activities.
The di¡erence in the activity of the two isoforms could be
attributed to amino acid di¡erences, which lie outside the
proposed active site of the toxin. Of the 12 di¡erences between
saporin-5 and saporin-6, substitutions at positions 134(Q/K),
147(S/L), 149(S/F), 162(D/N), 188(I/T) and 196(N/D) result in
change in polarity or charge of amino acid residue. Based on
a putative model of saporin, Fabbrini et al. [24] had postu-
lated the substitution of Lys134 of seed type saporin with Gln
in leaf cDNA isoform to be responsible for di¡erence in their
activity. This residue was predicted to be located at a con-
served surface loop of RNA binding domain. Crystal struc-
ture of saporin-6 showed that Lys134 is present in a hydro-
gen-bonded turn and Asp196 is present in a loop. Substitution
of charged amino acids Lys134 or Asp196 in saporin-6 with
uncharged amino acids Gln or Asn respectively in saporin-5
may result in a change in local structure as well as charge,
which can a¡ect the toxin interactions and activity on the
ribosomes. The two isoforms do not appear to di¡er in their
cell binding and internalization activities, and the binding of
saporin to various cell lines does not appear to be only
through LRP.
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